Fangming Gu

Perioperative camrelizumab plus rivoceranib versus surgery alone in patients with resectable hepatocellular carcinoma at intermediate or high risk of recurrence (CARES-009): a randomised phase 2/3 trial

Zheng Wang, Jia Fan, Shao‐Lai Zhou et al. · The Lancet · 2025 · 37 citations

Medicine, Oncology, Surgery +13

High-throughput sequencing approach for the identification of lncRNA biomarkers in hepatocellular carcinoma and revealing the effect of ZFAS1/miR-150-5p on hepatocellular carcinoma progression

Peng Zhu, Yongyan Pei, Jian Yu et al. · PeerJ · 2023 · 19 citations · Full text

Medicine, Molecular Biology, Oncology +17

Semi-supervised weighted distance metric learning for kNN classification

Fangming Gu, Dayou Liu, Xinying Wang · 2010 · 10 citations

Computing, Computer Science, Data Mining +16